MRNA has room to run. The market has yet to figure out that the confluence of Pfizer's findings on mrna vaccine efficacy w/booster + the Danish press surrounding "society-wide" Omicron infection will push MRNA back to the $400 range. Big day coming.$Moderna, Inc.(MRNA)$
精彩评论